Virotherapy for Brain Tumors - Defining the Path to Success

Evanthia Galanis

doi:10.1056/NEJMe2205032

Virotherapy for Brain Tumors - Defining the Path to Success

Medical Oncology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2520-2522
Number of pages	3
Journal	New England Journal of Medicine
Volume	386
Issue number	26
DOIs	https://doi.org/10.1056/NEJMe2205032
State	Published - Jun 30 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMe2205032

Cite this

@article{86c2eaea60384534a6c09d12a19d3b25,

title = "Virotherapy for Brain Tumors - Defining the Path to Success",

author = "Evanthia Galanis",

year = "2022",

month = jun,

day = "30",

doi = "10.1056/NEJMe2205032",

language = "English (US)",

volume = "386",

pages = "2520--2522",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "26",

}

TY - JOUR

T1 - Virotherapy for Brain Tumors - Defining the Path to Success

AU - Galanis, Evanthia

PY - 2022/6/30

Y1 - 2022/6/30

UR - http://www.scopus.com/inward/record.url?scp=85133214294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133214294&partnerID=8YFLogxK

U2 - 10.1056/NEJMe2205032

DO - 10.1056/NEJMe2205032

M3 - Editorial

C2 - 35767443

AN - SCOPUS:85133214294

SN - 0028-4793

VL - 386

SP - 2520

EP - 2522

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 26

ER -

Virotherapy for Brain Tumors - Defining the Path to Success

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this